37
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Processing of autologous bone marrow cells by apheresis technology for cell-based cardiovascular regeneration

, , , , &
Pages 1005-1010 | Received 17 Feb 2012, Accepted 30 Apr 2012, Published online: 18 Jun 2012

References

  • Charwat S, Gyöngyösi M, Lang I, Graf S, Beran G, Hemetsberger R, . Role of adult bone marrow stem cells in the repair of ischemic myocardium: current state of the art. Exp Hematol. 2008;36:672–80.
  • Fadini GP, Agostini C, Avogaro A. Autologous stem cell therapy for peripheral arterial disease: meta-analysis and systematic review of the literature. Atherosclerosis. 2010;209: 10–17.
  • Caplice NM, Gersh BJ, Alegria JR. Cell therapy for cardiovascular disease: what cells, what diseases and for whom? Nat Clin Pract Cardiovasc Med. 2005;2:37–43.
  • Lu J, Pompili VJ, Das H. Neovascularization and hematopoietic stem cells. Cell Biochem Biophys. 2011;DOI: 10.1007/s12013-011–9298-x.
  • Thum T, Bauersachs J, Poole-Wilson PA, Volk HD, Anker SD. The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle. J Am Coll Cardiol. 2005;46:1799–802.
  • Engelmann MG, Theiss HD, Hennig-Theiss C, Huber A, Wintersperger BJ, Werle-Ruedinger AE, . Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony- Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial. J Am Coll Cardiol. 2006;48:1712–21.
  • Kumar AH, Caplice NM. Clinical potential of adult vascular progenitor cells. Arterioscler Thromb Vasc Biol. 2010;30: 1080–7.
  • Iwasaki H, Kawamoto A, Ishikawa M, Oyamada A, Nakamori S, Nishimura H, . Dose-dependent contribution of CD34-positive cell transplantation to cocurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction. Circulation. 2006;113: 1311–25.
  • Meluzin J, Mayer J, Groch L, Janousek S, Hornacek I, Hlinomaz O, . Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function. Am Heart J. 2006;152:975 e9–15.
  • Hofmann M, Wollert KC, Meyer GP, Menke A, Arseniev L, Hertenstein B, . Monitoring of bone marrow cells homing into the infarcted human myocardium. Circulation. 2005;111: 2198–202.
  • Schächinger V, Aicher A, Döbert N, Röver R, Diener J, Fichtlscherer S, . Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium. Circulation. 2008;118:1425–32.
  • Venkatesan T, George SP. Stem cell therapy of myocardial dysfunction: are there any anaesthetic implications for autologous bone marrow harvest? Letter. Acta Anaesthesiol Scand. 2006;50:644.
  • Ben-Dor I, Fuchs S, Kornowski R. Potential hazards and technical considerations associated with myocardial cell transplantation protocols for ischemic myocardial syndrome. J Am Coll Cardiol. 2006;48:1519–26.
  • Griesel C, Heuft HG, Herrmann D, Franke A, Ladas D, Stiehler N, . Good manufacturing practice-compliant validation and preparation of BM cells for the therapy of acute myocardial infarction. Cytotherapy. 2007;9:35–43.
  • Donnenberg AD, Donnenberg VS, Griffin DL, Moore LR, Tekinturhan F, Kormos RL. Intra-operative preparation of autologous bone marrow-derived CD34-enriched cellular products for cardiac therapy. Cytotherapy. 2011;13: 441–8.
  • Seeger FH, Tonn T, Krzossok N, Zeiher AM, Dimmeler S. Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur Heart J. 2007;28:766–72.
  • Baker PK, Rhodes EG, Duguid JK. Continuous flow cell separator use for bone marrow processing. Transfusion Sci. 1991;12:183–7.
  • Koristek Z, Mayer J. Bone marrow processing for transplantation using the COBE Spectra separator. J Hematother Stem Cell Res. 1999;8:443–8.
  • Guttridge MG, Sidders C, Booth-Davey E, Pamphilon D, Watt SM. Factors affecting volume reduction and red blood cell depletion of bone marrow on the COBE Spectra cell separator before haematopoietic stem cell transplantation. Bone Marrow Transplantation. 2005;35:1035–9.
  • Nyolczas N, Gyöngyösi M, Beran G, Dettke M, Graf S, Sochor H, . Design and rationale for the myocardial stem cell administration after acute myocardial infarction (MYSTAR) study: a multicenter, prospective, randomized, single-blind trail comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction. Am Heart J. 2007;153:12e1–7.
  • Gyöngyösi M, Lang I, Dettke M, Beran G, Graf S, Sochor H, . Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study. Nat Clin Pract Cardiovasc Med. 2009;6:70–81.
  • Charwat S, Lang I, Dettke M, Graf S, Nyolczas N, Hemetsberger R, . Effect of intramyocardial delivery of autologous bone marrow mononuclear stem cells on the regional myocardial perfusion. NOGA-guided subanalysis of the MYSTAR prospective randomised study. Thromb Haemost. 2010;103:564–71.
  • Dettke M, Jurko S, Rüger BM, Leitner G, Greinix HT, Kalhs P, . Increase in the serum level of flt3-ligand after administration of G-CSF in healthy donors undergoing peripheral stem cell harvest. J Hematother Stem Cell Res. 2001;10:317–20.
  • O’Brien MC, Bolton WE. Comparison of cell viability probes compatible with fixation and permeabilization for combined surface and intracellular staining in flow cytometry. Cytometry. 1995;19:243–55.
  • Astori G, Bambi F, Soldati G, Sürder D, Moccetti T. Autologous bone marrow mononucleated cell preparation for the clinical treatment of acute myocardial infarction and peripheral arterial disease. Cytotherapy. 2011;13:1031–5.
  • Goldman JM. A special report. Bone marrow transplants using volunteer donors: recommendations and requirements for a standardized practice throughout the world. 1994 update. The WMDA Executive Committee. Blood. 1994;84:2833–9.
  • Tang WHW, Wilson T, Jain A, Francis GS, Harris M, Young JB. Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure. J Am Coll Cardiol. 2008;51:569–76.
  • Lannert H, Able T, Becker S, Sommer M, Braun M, Stadtherr P, Ho AD. Optimizing BM harvesting from normal adult donors. Bone Marrow Transplant. 2008;42:443–7.
  • Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, Wang T, Gregg D, Ramaswami P, . Aging, progenitor cell exhaustion, and atherosclerosis. Circulation. 2003;108:57–63.
  • Fadini GP, Miorin M, Facco M, Bonamico S, Baesso I, Grego F, . Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol. 2005;45:1449–57.
  • Kissel CK, Lehmann R, Assmus B, Aicher A, Honold J, Fischer-Rasokat U, . Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure. J Am Coll Cardiol. 2007;49: 2341–9.
  • Tol M, Akar AR, Durdu S, Ayyildiz, Ilhan O. Comparison of different needle diameters and flow rates on bone marrow mononuclear stem cell viability: an ex vivo experimental study. Cytotherapy. 2008;10:98–9.
  • Lowder JN, Whelton P. Microbial contamination of cellular products for hematolymphoid transplantation therapy: assessment of the problem and strategies to minimize the clinical impact. Cytotherapy. 2003;5:377–90.
  • Groenveld HF, Januzzi JL, Damman K, Wijngaarden van J, Hillege HL, van Veldhuisen DJ, Meer van der P. Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol. 2008;52:818–27.
  • Ciobanu N, Weinberg V, Sparano JA, Zervos G, Walewski J, Spivack M, Woernik PH. Experience with autologous bone marrow harvesting and transfusion of marrow-derived red cells. Transfusion. 1992;32:231–4.
  • Council of Europe Publishing. Guide to the Preparation Use and Quality Assurance of Blood Components. Strasbourg: Council of Europe Publishing, 2006.
  • Leitner GC, Dettke M, List J, Worel N, Weigel G, Fischer MB. Red blood units collected from bone marrow harvests after mononuclear cell selection qualify for autologous use. Vox Sang. 2010;98:e284–9.
  • Innerhofer P, Wiedermann FJ, Tiefenthaler W, Schobersberger W, Klingler A, Velik-Salchner C, . Are leukocytes in salvaged washed autologous blood harmful for the recipient? The results of a pilot study. Anesth Analg. 2001;93:566–72.
  • Breitbach M, Bostani T, Roell W, Xia Y, Dewald O, Nygren JM, . Potential risks of bone marrow cell transplantation into infarcted hearts. Blood. 2007;110:1362–9.
  • Yousef M, Schannwell CM, Köstering M, Zeus T, Brehm M, Strauer BE. The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction. J Am Coll Cardiol. 2009;53:2262–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.